Despite a $400 million impairment charge, analysts say the removal of a drug-device combo from its portfolio is not a huge ...

Like many tech stocks, Alphabet's (NASDAQ: GOOGL) (NASDAQ: GOOG) stock pulled back in recent months. Investors still question ...

Biotech stocks took a hit after the sudden resignation of Dr. Peter Marks, head of the FDA’s Center for Biologics Evaluation ...

Moderna's mRNA technology gained rapid validation as sales of its covid vaccine soared in 2021 and 2022, but we think the firm has yet to secure a narrow economic moat around its business, largely due ...

The sudden resignation of Peter Marks, M.D., Ph.D., from the FDA branch that regulates biological products for humans ...

This marks an 8% increase over the amount invested during the same period in 2024, and a slight 1% decline compared to the ...

Google has launched Gemini 2.5, designed to tackle increasingly complex problems. The first 2.5 model, Gemini 2.5 Pro Experimental, showcases strong reasoning and code capabilities, writes Koray ...

Google has announced that Gemini 2.5 Pro is now also free to use. Last week, only paying Advanced users had access to ...

This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the world of ...

Data science remains one of the most sought-after professions throughout industries. Advanced analytical skills are highly ...

We recently published a list of 10 Debt Free Halal Stocks to Invest in Right Now. In this article, we are going to take a ...